Attention should be paid to the studies on the clinical and immunological mechanism of systemic lupus erythematosus and accelerated coronary atherosclerosis
1Urowitz MB, Bookman AA, Koehler BE, et al. The bimodal mortality pattern of SLE. Am J Med, 1976,60:221-225.
2Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.Am J Epidemiol, 1997,145 : 408-415.
3Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy.Am J Med, 1975,58:243-264.
4Vaarala O, Alfthan G, Jauhiainen M, et al. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in SLE. Lancet, 1993,341:923-925.
5Shoenfeld Y, Harats D, George J. Atherosclerosis and the antiphospholipid syndrome: a link unravelled? Lupus, 1998(suppl2) :S140-S143.
6Krause I, Blank M, Shoenfeld Y. Immunomodulation of experimental APS: lessons from murine models. Lupus, 1996,5: 458-462.
7Petri M. Cardiovascular morbidity in the Hopkins lupus cohort.In: Shoenfeld Y, Harats D, Wick G, eds. Atherosclerosis and autoimmunity. Amsterdam: Elsevier, 2001. 249-254.
8Manzi S, Kuller LH, Edmundowicz D, et al. Vascular imaging:changing the face of cardiovascular research. Lupus, 2000, 9:176-182.
9Seizer F, Sutton Tyrrell K, Fitzgerald S, et al. Vascular stiffness in women with systemic lupus erythernatosus. Hypertension,2001,37: 1075-1082.
10Rahman P, Urowitz MB, Gladman DD, et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol, 1999, 26: 2363-2368.
2Turesson C,Matteson EL.Cardiovascular risk factors,fitness and physical activity in rheumatic diseases[J].Curr Opin Rheumatol,2007,19(2):190-196.
3Maradit-Kremers H,Nicola PJ,Crowson CS,et al.Cardiovascular death in rheumatoid arthritis:apopulation-based study[J].Arthritis Rheum,2005,52(3):722-732.
4Libby P.Inflammation in atherosclerosis[J].Arterioscler Thromb Vasc Biol,2012,32(9):2045-2051.
5Roman MJ,Crow MK,Lockshin MD,et al.Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus[J].Arthritis Rheum,2007,56(10):3412-3419.
6McCully KS.Vascular pathology of homocysteinemia:implications for the pathogenesis of arteriosclerosis[J].Am J Pathol,1969,56(1):111-128.
7Homocysteine Studies Collaboration.Homocysteine and risk of ischemic heart disease and stroke:a meta-analysis[J].JAMA,2002,288(16):2015-2022.
8Wald DS,Law M,Morris JK.Homocysteine and cardiovascular disease:evidence on causality from a meta-analysis[J].BMJ,2002,325(7374):1202.
9Jones BG,Rose FA,Tudball N.Lipid peroxidation and homocysteine induced toxicity[J].Atherosclerosis,1994,105(2):165-170.
10Roman MJ,Naqvi TZ,Gardin JM,et al.Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification:a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology[J].J Am Soc Echocardiogr,2006,19(8):943-954.
